|
Todd J. Yancey M.D. joined Onyx in August 2006 as Vice President Medical Affairs. Previously Dr. Yancey was a Medical Director at Genentech. His group provided medical oversight for the Tarceva drug development program and product life-cycle management. In this role he oversaw the Investigator Sponsored Trial program provided Medical Science Liaison and commercial support and managed scientific education initiatives. From 2002 to 2005 Dr. Yancey was at Amgen in both the U.S. and European Oncology organizations and also served as Director and Team Leader Inflammation Regional Medical Liaisons. Prior to Amgen he was the Senior Vice President of Medical and Scientific Affairs at BESTMED the medical communications arm of Saatchi and Saatchi. Dr. Yancey earned his M.D. and B.A. at the University of Virginia and completed his residency and fellowship training at The New York Hospital-Cornell University Medical College. | 